Helsinn is a global pharmaceutical company.
We provide products that improve the lives of patients with cancer and chronic diseases.
Helsinn operates a unique integrated licensing business model.
We have a comprehensive technical organization.
We’re advancing ESG initiatives that contribute to our sustainable growth.
Our mission is to improve the lives of patients all over the world.
